Skip to main content
Top
Published in: CardioVascular and Interventional Radiology 3/2008

01-05-2008 | Technical Note

Evaluation of Hepatic Angiography Procedures and Bremsstrahlung Imaging in Selective Internal Radiation Therapy: A Two-Year Single-Center Experience

Authors: A. J. Sebastian, T. Szyszko, A. Al-Nahhas, K. Nijran, N. P. Tait

Published in: CardioVascular and Interventional Radiology | Issue 3/2008

Login to get access

Abstract

The imaging of Bremsstrahlung radiation is performed after hepatic radioembolization to assess the distribution of the injected radioactive material. This review assesses the role of Bremsstrahlung imaging and its relation to the angiographic procedure and technique in hepatic selective internal radiation therapy on 21 patients undergoing this procedure at a single center.
Literature
1.
go back to reference Beheshti MV, Denny DF Jr, Glickman MG, Bodden W, Marsh JC, Strair R, Ravikumar TS (1992) Percutaneous isolated liver perfusion for treatment of hepatic malignancy: preliminary report. J Vasc Interv Radiol 3(3):453–458PubMedCrossRef Beheshti MV, Denny DF Jr, Glickman MG, Bodden W, Marsh JC, Strair R, Ravikumar TS (1992) Percutaneous isolated liver perfusion for treatment of hepatic malignancy: preliminary report. J Vasc Interv Radiol 3(3):453–458PubMedCrossRef
2.
go back to reference Lau WY, Leung WT, Ho S, Leung NW, Chan M, Lin J, Metrewell C, Johnson P, Li AK (1994) Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study. Br J Cancer 70(5):994–999PubMed Lau WY, Leung WT, Ho S, Leung NW, Chan M, Lin J, Metrewell C, Johnson P, Li AK (1994) Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study. Br J Cancer 70(5):994–999PubMed
3.
go back to reference Salem R. Lewandowski RJ, Atassi B, Gordon SC, Gares VL, Barakat O, Sergie Z, Wong CY, Thurston KG (2005) Treatment of unresectable hepatocellular carcinomas with use of 90Y microspheres (TheraSphere): safety, tumour response and survival. J Vasc Interv Radiol 16(12):1627–1639 Salem R. Lewandowski RJ, Atassi B, Gordon SC, Gares VL, Barakat O, Sergie Z, Wong CY, Thurston KG (2005) Treatment of unresectable hepatocellular carcinomas with use of 90Y microspheres (TheraSphere): safety, tumour response and survival. J Vasc Interv Radiol 16(12):1627–1639
4.
go back to reference Gray BN, Anderson JE, Burton MA, Van Hazel G, Codde J, Morgan C, Klemp P (1992) Regression of liver metastases following treatment with yttrium-90 microspheres. Aust NZ J Surg 62(2):105–110 Gray BN, Anderson JE, Burton MA, Van Hazel G, Codde J, Morgan C, Klemp P (1992) Regression of liver metastases following treatment with yttrium-90 microspheres. Aust NZ J Surg 62(2):105–110
5.
go back to reference Van Hazel G, Blackwell A, Anderson J, Price D, Moroz P, Bower G, Cardaci G, Gray B (2004) Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy vs fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 88:78–85PubMedCrossRef Van Hazel G, Blackwell A, Anderson J, Price D, Moroz P, Bower G, Cardaci G, Gray B (2004) Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy vs fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 88:78–85PubMedCrossRef
6.
go back to reference Gray B, Van Hazel G, Hope M, Burton M, Moroz P, Anderson J, Gebshi V (2001) Randomised trial of SIR-Spheres plus chemotherapy vs chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 12(12):1711–1720PubMedCrossRef Gray B, Van Hazel G, Hope M, Burton M, Moroz P, Anderson J, Gebshi V (2001) Randomised trial of SIR-Spheres plus chemotherapy vs chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 12(12):1711–1720PubMedCrossRef
7.
go back to reference Stubbs RS, CannanRJ, Mitchell AW (2001) Selective internal radiation therapy with 90-ytrrium microspheres for extensive colorectal liver metastases. Hepatogastroenterology 48(38):333–337PubMed Stubbs RS, CannanRJ, Mitchell AW (2001) Selective internal radiation therapy with 90-ytrrium microspheres for extensive colorectal liver metastases. Hepatogastroenterology 48(38):333–337PubMed
8.
go back to reference EC-SIR-Spheres user’s manual. Physician and institution information for SIR-Spheres. SIRTEX Medical (Europe) Ltd EC-SIR-Spheres user’s manual. Physician and institution information for SIR-Spheres. SIRTEX Medical (Europe) Ltd
9.
go back to reference Sato KT, Salem R, Haines K et al (2006) Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere®): assessment of hepatic arterial embolization. CardioVasc Interv Radiol 29:522–529CrossRef Sato KT, Salem R, Haines K et al (2006) Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere®): assessment of hepatic arterial embolization. CardioVasc Interv Radiol 29:522–529CrossRef
10.
go back to reference Murthy R et al (2005) Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results. J Vasc Interv Radiol 16:937–945PubMed Murthy R et al (2005) Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results. J Vasc Interv Radiol 16:937–945PubMed
11.
go back to reference Jackson JJ (1999) Vascular anatomy of the gastrointestinal tract. In: Butler P, Mitchell A, Ellis H (eds) 1999 applied radiological anatomy. Cambridge University Press, Cambridge, pp 223–237 Jackson JJ (1999) Vascular anatomy of the gastrointestinal tract. In: Butler P, Mitchell A, Ellis H (eds) 1999 applied radiological anatomy. Cambridge University Press, Cambridge, pp 223–237
12.
go back to reference Lewandowski RJ, Salem R (2004) Incidence of radiation cholecystitis in patients receiving Y-90 treatment for unresectable liver malignancies. J Vasc Interv Radiol 15(2; pt 2):S162 (abstr) Lewandowski RJ, Salem R (2004) Incidence of radiation cholecystitis in patients receiving Y-90 treatment for unresectable liver malignancies. J Vasc Interv Radiol 15(2; pt 2):S162 (abstr)
13.
go back to reference Ayav A, Habib N, Jiao LR (2005) Portal hypertension secondary to 90-yttrium microspheres: an unknown complication. J Clin Oncol 23:8275–8276PubMedCrossRef Ayav A, Habib N, Jiao LR (2005) Portal hypertension secondary to 90-yttrium microspheres: an unknown complication. J Clin Oncol 23:8275–8276PubMedCrossRef
Metadata
Title
Evaluation of Hepatic Angiography Procedures and Bremsstrahlung Imaging in Selective Internal Radiation Therapy: A Two-Year Single-Center Experience
Authors
A. J. Sebastian
T. Szyszko
A. Al-Nahhas
K. Nijran
N. P. Tait
Publication date
01-05-2008
Publisher
Springer-Verlag
Published in
CardioVascular and Interventional Radiology / Issue 3/2008
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-008-9298-4

Other articles of this Issue 3/2008

CardioVascular and Interventional Radiology 3/2008 Go to the issue